| Corneal confocal microscopy: a biomarker for diabetic peripheral neuropathy IN Petropoulos, G Ponirakis, M Ferdousi, S Azmi, A Kalteniece, A Khan, ... Clinical therapeutics 43 (9), 1457-1475, 2021 | 47 | 2021 |
| Lipids and peripheral neuropathy Z Iqbal, B Bashir, M Ferdousi, A Kalteniece, U Alam, RA Malik, H Soran Current Opinion in Lipidology 32 (4), 249-257, 2021 | 42 | 2021 |
| Paraoxonase 1 and atherosclerosis PN Durrington, B Bashir, H Soran Frontiers in Cardiovascular Medicine 10, 1065967, 2023 | 38 | 2023 |
| Non-diabetic ketoacidosis: a case series and literature review B Bashir, AA Fahmy, F Raza, M Banerjee Postgraduate Medical Journal 97 (1152), 667-671, 2021 | 26 | 2021 |
| Severe hypertriglyceridaemia and chylomicronaemia syndrome—causes, clinical presentation, and therapeutic options B Bashir, JH Ho, P Downie, P Hamilton, G Ferns, D Datta, J Cegla, ... Metabolites 13 (5), 621, 2023 | 19 | 2023 |
| Microvascular complications of obesity and diabetes—Role of bariatric surgery B Bashir, Z Iqbal, S Adam, M Ferdousi, W Chick, HA Hussein, AA Syed, ... Obesity Reviews 24 (10), e13602, 2023 | 16 | 2023 |
| Lipids, lipid-lowering therapy, and neuropathy: a narrative review R Pasha, S Azmi, M Ferdousi, A Kalteniece, B Bashir, I Gouni-Berthold, ... Clinical Therapeutics 44 (7), 1012-1025, 2022 | 11 | 2022 |
| Glycated apolipoprotein B decreases after bariatric surgery in people with and without diabetes: A potential contribution to reduction in cardiovascular risk Z Iqbal, B Bashir, S Adam, JH Ho, S Dhage, S Azmi, M Ferdousi, Z Yusuf, ... Atherosclerosis 346, 10-17, 2022 | 10 | 2022 |
| Efficacy and safety of PCSK9 monoclonal antibodies in patients with Diabetes BH Marouf, Z Iqbal, JB Mohamad, B Bashir, J Schofield, A Syed, ... Clinical Therapeutics 44 (2), 331-348, 2022 | 10 | 2022 |
| Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from … B Bashir, AS Wierzbicki, A Jones, C Dawson, P Downie, F Jenkinson, ... Atherosclerosis 391, 117476, 2024 | 6 | 2024 |
| Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia B Bashir, J Schofield, P Downie, M France, DM Ashcroft, AK Wright, ... Frontiers in Cardiovascular Medicine 11, 1389106, 2024 | 5 | 2024 |
| Established and potential cardiovascular risk factors in metabolic syndrome: Effect of bariatric surgery B Bashir, S Adam, JH Ho, Z Linn, PN Durrington, H Soran Current Opinion in Lipidology 34 (5), 221-233, 2023 | 4 | 2023 |
| Lipoprotein (a) in familial hypercholesterolaemia PN Durrington, B Bashir, D Bhatnagar, H Soran Current opinion in lipidology 33 (4), 257-263, 2022 | 4 | 2022 |
| Protein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies (PCSK9mab) in Clinical Practice at Secondary Care–Real World Multicentre Experience B Bashir, S Haslam, S Ahmad, MN Elnaggar, R Allcock, S Ali, NM Kyi, ... Cureus 14 (12), 2022 | 3 | 2022 |
| Ethnic diversity and distinctive features of familial versus multifactorial chylomicronemia syndrome: insights from the UK FCS National Registry B Bashir, P Downie, N Forrester, AS Wierzbicki, C Dawson, A Jones, ... Arteriosclerosis, Thrombosis, and Vascular Biology 44 (11), 2334-2346, 2024 | 2 | 2024 |
| Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia B Bashir, M Ferdousi, P Durrington, H Soran Current Opinion in Lipidology 35 (4), 208-218, 2024 | 2 | 2024 |
| What should be the goal of cholesterol-lowering treatment? A quantitative evaluation dispelling guideline myths PN Durrington, B Bashir, H Soran Current Opinion in Lipidology 33 (4), 219-226, 2022 | 2 | 2022 |
| The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes: An examination of the available evidence S Adam, JH Ho, B Bashir, Z Iqbal, M Ferdousi, AA Syed, H Soran Current opinion in lipidology 32 (4), 231-243, 2021 | 2 | 2021 |
| The Role of Glucagon-Like Peptide 1 Receptor PET/CT With Ga-68-NODAGA-exendin in Localising an Insulinoma: Lessons From a Clinical Case VC Grigoriadou, A Kapoor, A Khan, B Bashir, M Kelly, G Wark, S Jamdar, ... Journal of the Endocrine Society 5 (Supplement_1), A614-A614, 2021 | 2 | 2021 |
| The Effects of Bariatric Surgery on the Requirement for Antihypertensive Treatment in Type 2 Diabetes: Insights from a Long-Term Follow-Up Study A Heald, F Mannan, R Wiltshire, P Ghaffari, U Waheed, D Zdravkovic, ... Diabetes Therapy 15 (9), 2097-2107, 2024 | 1 | 2024 |